Literature DB >> 8773289

Carbamazepine clinical pharmacology: a review.

F Albani1, R Riva, A Baruzzi.   

Abstract

The tricyclic anticonvulsant carbamazepine is being increasingly used to treat a variety of neuropsychiatric disorders. We review the literature on the drug in neurology, psychiatry, and pharmacology, in order to provide the clinical psychiatrist with a comprehensive reference on carbamazepine pharmacokinetics, toxicity, and drug interactions. We also present an overview of the psychiatric disorders in which carbamazepine has been found, or suggested, to be efficacious.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8773289     DOI： 10.1055/s-2007-979609

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN： 0176-3679            Impact factor:   5.788


  17 in total

Review 1.  Developmental neuropathology of environmental agents.

Authors:  Lucio G Costa; Michael Aschner; Annabella Vitalone; Tore Syversen; Offie Porat Soldin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

2.  Induction of the metabolism of etizolam by carbamazepine in humans.

Authors:  S Kondo; T Fukasawa; N Yasui-Furukori; T Aoshima; A Suzuki; Y Inoue; T Tateishi; K Otani
Journal:  Eur J Clin Pharmacol       Date:  2005-03-18       Impact factor: 2.953

3.  Pharmacokinetic simulation of fatal carbamazepine intoxication in 23-month old child following phenytoin discontinuation.

Authors:  Jineane V Venci; Meghan M Rowcliffe; Lance Wollenberg; Michelle M Rainka; Fran M Gengo
Journal:  Forensic Sci Med Pathol       Date:  2012-08-23       Impact factor: 2.007

4.  The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers.

Authors:  J J Miceli; R J Anziano; L Robarge; R A Hansen; A Laurent
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

5.  Treatment of alcohol withdrawal syndrome with a combination of tiapride/carbamazepine: results of a pooled analysis in 540 patients.

Authors:  Michael Soyka; Peggy Schmidt; Michael Franz; Thomas Barth; Michael de Groot; Thorsten Kienast; Thomas Reinert; Christoph Richter; Greif Sander
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08-17       Impact factor: 5.270

6.  Hippocratic psychopharmacology for Bipolar Disorder-An Expert's Opinion.

Authors:  S Nassir Ghaemi
Journal:  Psychiatry (Edgmont)       Date:  2006-06

7.  Synthesis of heterocycles via Pd-ligand controlled cyclization of 2-chloro-N-(2-vinyl)aniline: preparation of carbazoles, indoles, dibenzazepines, and acridines.

Authors:  Dmitry Tsvelikhovsky; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2010-10-13       Impact factor: 15.419

8.  Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers.

Authors:  Andreas Johne; Elke S Perloff; Steffen Bauer; Jürgen Schmider; Ingrid Mai; Jürgen Brockmöller; Ivar Roots
Journal:  Eur J Clin Pharmacol       Date:  2004-09-15       Impact factor: 2.953

9.  Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care Physicians.

Authors:  Raphael J. Leo; Rajesh Narendran
Journal:  Prim Care Companion J Clin Psychiatry       Date:  1999-06

10.  Transitional polytherapy: tricks of the trade for monotherapy to monotherapy AED conversions.

Authors:  William R Garnett; Erik K St Louis; Thomas R Henry; Thomas Bramley
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.